VANCOUVER, British Columbia - illiNews -- Scientists today now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead our body and brain to decline as we age. Many believe that inflammation, stress, diet, exercise, and genetics greatly contribute to our aging process.
New studies are pointing to promising treatments that could slow, stop, or even reverse the signs of aging. This isn't just about turning back the clock in order to have a longer life span, it's about extending our healthy years.
In one study, mice were given pills that mimicked the positive benefits of exercise. If it works in mice would it be effective in humans? And what does this portend for the future, if our lifespan increases and we all live decades longer?
The business of anti-aging and rejuvenation is gaining steam and should be on the radar of investors — the Bank of America has forecasted that the market will balloon from $110 billion today, to nearly to $610 billion by 2025.
More on illi News
Researchers have jumped on this trend too. In 2012, only 73 trials were conducted to reverse aging and that number doubled by the end of 2017 to 145. In 2018, this industry accounted for the most significant amount of investment, as market participants attracted an amount close to $800M (for comparison, back in 2014, it was only about $100M). The number of investment deals is also growing, with the highest number of the past six years recorded in 2017 (25 according to CB Insights, up from 13 a year earlier).
Companies like Juvenescence have raised over $100M to advance multiple anti-aging programs. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully improve human health and extends our lifespan.
Here are additional industry developments we're excited about:
Juvenescence's portfolio currently includes Insilico Medicine, a next-generation artificial intelligence company specializing in the application of deep learning to drug discovery and aging research. Juvenescence AI, a joint venture with Insilico Medicine focused on the clinical development of AI-generated compounds.
More on illi News
UNITY Biotechnology, a company developing therapeutics to extend healthspan with an initial focus on cellular senescence..
AgeX Therapeutics, a company applying intellectual property related to cell immortality and pluripotency.
Finding the latest developments
Investors can follow the latest advancements in anti-aging and rejuvenation by reading magazines such as Nature and The New Scientist. Both publications recently featured interesting articles that highlighted recent developments. We also recommend following websites like fiercebiotech, scientificamerican (https://www.scientificamerican.com/), and tracking IPOs (https://www.nasdaq.com/market-activity/ipos) to find other companies developing innovative technologies
New studies are pointing to promising treatments that could slow, stop, or even reverse the signs of aging. This isn't just about turning back the clock in order to have a longer life span, it's about extending our healthy years.
In one study, mice were given pills that mimicked the positive benefits of exercise. If it works in mice would it be effective in humans? And what does this portend for the future, if our lifespan increases and we all live decades longer?
The business of anti-aging and rejuvenation is gaining steam and should be on the radar of investors — the Bank of America has forecasted that the market will balloon from $110 billion today, to nearly to $610 billion by 2025.
More on illi News
- Grab 'em by the Microphone! Independent Feature Film To the New Girl Releases on VOD
- Crossover Publications announces 9/11/2020 release date for Make America Saved Again
- Sustainable Student-Run Company's Diverse Work Environment Embodies American-Made Spirit
- e7 Health now offers at-home COVID-19 saliva test kits
- Maccabi USA Men's Basketball Announces New Head Coach For 21st Maccabiah
Researchers have jumped on this trend too. In 2012, only 73 trials were conducted to reverse aging and that number doubled by the end of 2017 to 145. In 2018, this industry accounted for the most significant amount of investment, as market participants attracted an amount close to $800M (for comparison, back in 2014, it was only about $100M). The number of investment deals is also growing, with the highest number of the past six years recorded in 2017 (25 according to CB Insights, up from 13 a year earlier).
Companies like Juvenescence have raised over $100M to advance multiple anti-aging programs. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully improve human health and extends our lifespan.
Here are additional industry developments we're excited about:
Juvenescence's portfolio currently includes Insilico Medicine, a next-generation artificial intelligence company specializing in the application of deep learning to drug discovery and aging research. Juvenescence AI, a joint venture with Insilico Medicine focused on the clinical development of AI-generated compounds.
More on illi News
- Genuine Hospitality, LLC Selected to Operate the New Home2 Suites by Hilton-Chicago/O'Hare International Airport
- Chicago: Mayor Lightfoot Joins Governor Pritzker and Blue Cross and Blue Shield of Illinois (BCBSIL) for Ribbon Cutting on New South Side Facility
- Naperville: Municipal Election Petitions for Candidacy Available Monday, Aug. 17
- Clarity Gold Reported 2.32 oz/t Au - Sent Crews to Three High Grade Gold Properties in BC
- Doctor Develops Personalized Solution to COVID-19 Threat
UNITY Biotechnology, a company developing therapeutics to extend healthspan with an initial focus on cellular senescence..
AgeX Therapeutics, a company applying intellectual property related to cell immortality and pluripotency.
Finding the latest developments
Investors can follow the latest advancements in anti-aging and rejuvenation by reading magazines such as Nature and The New Scientist. Both publications recently featured interesting articles that highlighted recent developments. We also recommend following websites like fiercebiotech, scientificamerican (https://www.scientificamerican.com/), and tracking IPOs (https://www.nasdaq.com/market-activity/ipos) to find other companies developing innovative technologies
Source: Braeden Lichti
0 Comments
Latest on illi News
- Schutt Sports Launches Multiple Splash Shield Products
- CDI Global Welcomes RVCO Consultants as its New Member Firm in India
- Chicago: Mayor Lightfoot and BACP Announce $500,000 RFP For Regional Business Centers
- ITSMA Announces Finalists for the 2020 Marketing Excellence Awards
- Tom Urquhart, Ph.D., joins IOTech Systems as SVP of Professional Services
- CEO Coaching International Client, StoneAge Inc., Acquires Breadware, A Leader in Industrial IOT Product Development
- Would you hand your 16-year-old son the keys to your new Ferrari?
- Ideanomics Announces Q2 2020 Earnings - TESLA Model 3 Proof of Concept
- Kupit Kickstarter Campaign by Burgeón Brands Attempts to Reduce Waste from Single-Serving Coffee Pods
- Latino Leaders Network to Host Virtual Panel Discussion with Democratic Latino Delegates
- 360Quadrants releases Best Artificial Intelligence (AI) Software providers in 2020
- Evolve IP Delivers World's Only Omnichannel Contact Center Integrated with Microsoft Teams and Virtual Workspaces
- Mahmood Khan hits number 1 on Billboard
- Music Vocabulary to Build Lesson Plans for Early Childhood and Elementary School Students
- Hitting the Ground Running With e-Commerce
- High Throughput Industrial NAS Storage Server Solution For Real-Time Data processing, Recording and Streaming
- Naperville: Crime Stoppers Reward Offered for Information in Theft of Puppy from Pet Store
- Parenting Kids with ADHD and Related Challenges Just Got A Lot Easier
- Barks in the Bottoms During These Dog Days of Summer in Kansas City's West Bottoms
- DeRonja Real Estate Welcomes Greyson Sargent